SIGA Technologies Target of Unusually Large Options Trading (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGA - Get Free Report) was the recipient of some unusual options trading on Wednesday. Investors bought 1,200 call options on the stock. This represents an increase of approximately 1,438% compared to the typical daily volume of 78 call options.

SIGA Technologies Stock Up 1.0 %

Shares of SIGA stock traded up $0.06 on Thursday, hitting $6.06. The stock had a trading volume of 300,845 shares, compared to its average volume of 848,713. SIGA Technologies has a one year low of $4.26 and a one year high of $12.83. The business has a 50 day moving average price of $6.69 and a 200 day moving average price of $7.68. The company has a market cap of $432.71 million, a PE ratio of 5.05 and a beta of 0.89.

SIGA Technologies (NASDAQ:SIGA - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.02 EPS for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. The business had revenue of $10.01 million during the quarter. Equities research analysts expect that SIGA Technologies will post 1.04 EPS for the current year.

Institutional Trading of SIGA Technologies

A number of hedge funds have recently bought and sold shares of SIGA. Larson Financial Group LLC purchased a new stake in shares of SIGA Technologies during the third quarter valued at about $30,000. DekaBank Deutsche Girozentrale bought a new position in shares of SIGA Technologies during the 2nd quarter worth approximately $40,000. EP Wealth Advisors LLC purchased a new stake in SIGA Technologies during the third quarter valued at approximately $82,000. XTX Topco Ltd purchased a new stake in SIGA Technologies during the third quarter valued at approximately $85,000. Finally, AQR Capital Management LLC acquired a new stake in SIGA Technologies in the second quarter valued at approximately $99,000. Hedge funds and other institutional investors own 55.40% of the company's stock.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.